Long‐term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients—Functional cure unlikely-Reference-Cited by-同舟云学术

Long‐term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients—Functional cure unlikely

Published:2020-05-17 Issue:9 Volume:27 Page:951-954
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Cho Ju‐Yeon¹^ORCID,Sohn Won²^ORCID,Paik Yong‐Han³⁴,Gwak Geum‐Youn³^ORCID,Choi Moon Seok³,Lee Joon Hyeok³,Koh Kwang Cheol³,Paik Seung Woon³,Park Chan Guk¹

Affiliation:

1. Division of Gastroenterology and Hepatology Department of Medicine Chosun University Korea

2. Division of Gastroenterology and Hepatology Department of Medicine Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul Korea

3. Division of Gastroenterology and Hepatology Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Korea

4. Department of Health Science and Technology Samsung Advanced Institute for Health Science and Technology Sunkyunkwan University

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13306

Reference12 articles.

1. Hepatitis B virus.The major etiology of hepatocellular carcinoma

2. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

3. Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D

4. Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely

5. Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long-term nucleos(t)ide analogue therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management;World Journal of Hepatology;2024-04-27

2. Trend patterns of HBsAg kinetics in chronic hepatitis B patients during nucleos(t)ide analogue therapy based on ARMA models;Journal of the Formosan Medical Association;2023-06

3. Cases of Rapid Hepatitis B Surface Antigen Reduction after COVID-19 Vaccination;Internal Medicine;2023-01-01

4. Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL;Hepatology International;2022-03-24

5. Effect of Entecavir on the Intestinal Microflora in Patients with Chronic Hepatitis B: A Controlled Cross-Sectional and Longitudinal Real-World Study;Infectious Diseases and Therapy;2020-10-28